Chromogranin A (CgA) in the Diagnosis and Monitoring of Patients with Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NET): A Single-Institution Experience

被引：0
|
作者：
Massironi, S. [1 ]
Rossi, R. E.
Spampatti, M. P.
Casazza, G. [2 ]
Conte, D.
Ciafardini, C.
Cavalcoli, F.
Peracchi, M.
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[2] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
cga; gep-net;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [21] Comparative Analysis of Octreotide Long Acting Release (LAR) and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Single Institution Experience
    Wu, S.
    Reta-Impey, P.
    Manivannan, N.
    Tirumani, S. H.
    Fu, P.
    Cao, S.
    Asa, S.
    Kardan, A.
    Liu, F.
    Avril, N.
    Wojtylak, P.
    Lee, R.
    Bajor, D.
    Selfridge, E.
    Saltzman, J.
    Hardacre, J.
    Ammori, J.
    Winter, J.
    Mohamed, A.
    PANCREAS, 2021, 50 (03) : 448 - 449
  • [22] Efficacy and Safety of Targeted Agents for Treatment of Gastroenteropancreatic (GEP) Neuroendocrine Tumor (NET): Single Center Experience
    Yoo, C.
    Cho, H.
    Kim, K.
    Chang, H. M.
    Kim, T.
    Hong, Y. S.
    Song, M. J.
    Hong, S. M.
    Kim, S.
    Ryoo, B. Y.
    NEUROENDOCRINOLOGY, 2016, 103 : 85 - 85
  • [23] Bone Metastases (BM) in Neuroendocrine Tumors (NET): Imaging Characteristics and Clinical Implications. A Single-Institution Experience
    Smiroldo, V
    Lania, A.
    Pedicini, V
    Pepe, G.
    Zerbi, A.
    Vigano, L.
    Bozzarelli, S.
    Spaggiari, P.
    Rimassa, L.
    Carnaghi, C.
    NEUROENDOCRINOLOGY, 2020, 110 : 173 - 173
  • [24] Neuroendocrine tumors of the gastroenteropancreatic system (NET-GEP).: Experience, difficulties and achievements of a multidisciplinary team from Argentina
    Bestani, MC
    Méndez, G
    O'Connor, J
    Szyldergemajn, S
    Domenichini, E
    Cabanne, A
    Amat, M
    Chacón, M
    Marmissolle, F
    Genna, A
    Belli, S
    Sade, JP
    Pairola, A
    Roca, E
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 31 - 31
  • [25] Clinicopathologic features of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): A single-center experience.
    Telli, Tugba Akin
    Esin, Ece
    Yalcin, Suayib
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Colorectal Neuroendocrine Tumors of the Gastroenteropancreatic Tract (GEP-NET) - Minimal Invasive Surgery
    Szybinski, P.
    Klek, S.
    Hubalewska-Dydejczyk, A.
    Richter, P.
    Kulig, J.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 137 - 137
  • [27] Experience with 177Lu-Dotatate in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET): Report from a single urban cancer center.
    Kieft, Aria
    Ibrahim, Yahya
    Dyson, Gregory
    Baran, Geoffrey
    Azmi, Asfar S.
    Al Hallak, Mohammed Najeeb
    Shields, Anthony Frank
    Vaishampayan, Nitin
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18688 - E18688
  • [28] Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Tian, Tiantian
    Gao, Jing
    Li, Na
    Li, Yanyan
    Lu, Ming
    Li, Zhongwu
    Lu, Zhihao
    Li, Jie
    Shen, Lin
    PLOS ONE, 2016, 11 (05):
  • [29] Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients
    Chou, Wen-Chi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Jen-Shi
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    Rau, Kun-Ming
    Yeh, Kun-Yun
    Chen, Tse-Ching
    Sun, Chien-Feng
    NEUROENDOCRINOLOGY, 2012, 95 (04) : 344 - 350
  • [30] Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience
    Stivanello, M
    Berruti, A
    Torta, M
    Termine, A
    Tampellini, M
    Gorzegno, G
    Angeli, A
    Dogliotti, L
    ANNALS OF ONCOLOGY, 2001, 12 : S73 - S77
12345